Sarda Proteins Complete Financial Statements
In FYNone, Sarda Proteins (SRDAPRT) reported revenue ₹16 Cr, net profit ₹0 Cr and EPS ₹-1.90. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore Sarda Proteins stock price data download to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SRDAPRT Revenue, Net Profit & EBITDA — Year-on-Year Growth
SRDAPRT YoY (March 2025 vs Period) — revenue -33.3%, expenses -33.3%. For live price, earnings ratios and company overview, see SRDAPRT share price.
SRDAPRT Income Statement — Revenue, EBITDA & Net Profit
Sarda Proteins revenue ₹16 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹-1.90 (None). Analyse SRDAPRT institutional holdings to track promoter, FII and institutional holdings.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 24 | 2 | 6 | 11 | 11 | 6 | 7 | 6 | 6 | 2 | 5 |
| Expenses | 16 | 24 | 1 | 6 | 11 | 11 | 5 | 7 | 6 | 6 | 2 | 5 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | -11.00% | 0.00% | -11.00% | -3.00% | 3.00% | 0.00% | 2.00% | -1.00% | -6.00% | -3.00% | -6.00% | -3.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Earnings Per Share (₹) | -1.90 | 2.96 | 11.25 | -0.19 | 1.78 | -0.12 | 0.19 | -0.72 | -1.92 | -0.77 | -0.89 | 2.43 |
SRDAPRT Balance Sheet — Assets, Liabilities & Shareholders' Equity
SRDAPRT total assets ₹3 Cr, total equity ₹2 Cr, total liabilities ₹ Cr (2025).
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 3 |
| Current Assets | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Reserves & Surplus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SRDAPRT Cash Flow Statement — Operating, Investing & Financing
Sarda Proteins operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | -1 | -1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 1 |